European Commission: indication expansion of Halaven for advanced or metastatic breast cancer after only one prior chemotherapy
Eisai has announced that it has received approval from the European Commission ( EC ) of the indication expansion of Halaven ( Eribulin mesylate ) to contribute to earlier treatment of patients with l ...
read article